Publications

5808 Results

A phase II trial of response-adapted therapy of stage III-IV hodgkin lymphoma using early interim FDG-PET imaging: SWOG S0816

Authors
O Press;M LeBlanc;L Rimsza;H Schoder;J Friedberg;H Li;N Bartlett;A LaCasce;J Sweetenham;A Evens;D Strauss;M Knopp;A Noy;R Gascoyne;B Cheson;B Kahl;TP Miller;RI Fisher
Journal / Conference
Hematological Oncology 31(suppl.1):abstr. #24, p. 137; Intl Conference on Malignant Lymphoma (June 19-22, 2013, Lugano, Switzerland), oral presentation;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
S0816

A model for prediction of FLT3-ITD and NPM1 (without FLT-3-ITD) positivity in patients with newly diagnosed acute myeloid leukemia [correspondence]

Authors
F Ostronoff;M Othus;HM Kantarjian;S Meshinchi;F Ravandi;P Hendrie;S Faderl;P Becker;JE Cortes;JM Pagel;SH Petersdorf;JE Godwin;C Willman;SA Pierce;AF List;RK Sandhu;R Walter;D Stirewalt;FR Appelbaum;EH Estey
Journal / Conference
British Journal of Haematology 163(1):130-132;
Year
2013
Research Committee(s)
Leukemia
PMID
PMID23829510
PMC
PMC4128010
Study Number(s)
S0106, SWOG-9031, SWOG-9333, SWOG-9500

Deregulation of stem cell factor (SCF)-AKT-S6 pathway in diagnostic AML samples is associated with disease-free survival: results of a verification study

Authors
A Cesano;C Willman;K Kopecky;S Putta;A Cohen;MC Marimpietri;S Atwater;F Appelbaum;G Radich
Journal / Conference
Haematologica 98(suppl.1):abstr. #P956, p.396; European Hematology Association 18th Congress ( June 13-16, 2013, Stockholm, Sweden), poster presentation;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0112, S0301, SWOG-9031, SWOG-9333

Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405

Authors
K Van Loon;D Wigler;D Niedzwiecki;AP Venook;C Fuchs;C Blanke;L Saltz;RM Goldberg;JA Meyerhardt
Journal / Conference
Clinical Colorectal Cancer 12(2):95-102;
Year
2013
Research Committee(s)
Gastrointestinal
PMID
PMID23317558
PMC
PMC3790266
Study Number(s)
CTSU/C80405, C89803

Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies

Authors
JA Woyach;AS Ruppert;K Rai;TS Lin;S Geyer;J Kolitz;F Appelbaum;M Tallman;MS Tallman;AR Belch;VA Morrison;RA Larson;JC Byrd
Journal / Conference
Journal of Clinical Oncology 31(4):440-447
Year
2013
Research Committee(s)
Leukemia
PMID
PMID23233702
PMC
PMC3731920

Robust risk stratification model predicts local-regional recurrence after radical cystectomy in different patient cohorts

Authors
B Baumann;J He;W-T Hwang;K Tucker;S Lerner;C Tangen;H Herr;T Guzzo;SB Malkowicz;J Christodouleas
Journal / Conference
International Journal of Radiation Oncology * Biology * Physics 87(2):Supplement, p. S82; ASTRO annual meeting Sept. 22-25, 2013, Atlanta, GA), oral presentation;
Year
2013
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial

Authors
S Ogino;X Liao;Y Imamura;M Yamauchi;N McCleary;K Ng;D Niedzwiecki;L Saltz;RJ Mayer;R Whittom;A Hantel;A Benson;RB Mowat;D Spiegelman;RM Goldberg;M Bertagnolli;JA Meyerhardt;C Fuchs
Journal / Conference
Journal of the National Cancer Institute 105(23):1789-1798;
Year
2013
Research Committee(s)
Gastrointestinal
PMID
PMID24231454
PMC
PMC384898
Study Number(s)
C89803

Modeling the relationship between progression-free survival and overall survival: the phase 2/3 trial

Authors
M Redman;B Goldman;M LeBlanc;A Schott;LH Baker
Journal / Conference
Clinical Cancer Research, 19(10):2646-2656;
Year
2013
Research Committee(s)
Brain, Breast, Gastrointestinal, Gynecologic, Lung, Lymphoma, and Myeloma
PMID
PMID23669424
PMC
PMC4131693
Study Number(s)
S0001, S0124, SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12), SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415), SWOG-9438, SWOG-9509

Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial

Authors
BP Schneider;RJ Gray;M Radovich;F Shen;G Vance;L Li;G Jiang;J Gralow;MN Dickler;M Cobleigh;EA Perez;T Shenkier;K Vang Nielsen;S Muller;A Thor;G Sledge, Jr;JA Sparano;NE Davidson;SS Badve
Journal / Conference
Clinical Cancer Research 19(5):1281-1289
Year
2013
Research Committee(s)
Breast
PMID
PMID23340303
PMC
PMC3594423
Study Number(s)
CTSU/E2100

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

Authors
CF de Larrea;RA Kyle;BGM Durie;H Ludwig;S Usmani;DH Vesole;R Hajeck;JF San Miguel;O Sezer;P Sonneveld;SK Kumar;A Mahindra;RL Comenzo;A Palumbo;A Mazumber;KC Anderson;PG Richardson;AZ Badros;J Caers;M Cavo;X LeLeu;MA Dimopoulos;CS Chim;R Schots;A Noeul;D Fantl;UH Mellqvist;O Landgren;A Chanan-Khan;P Moreau;R Fonseca;G Merlini;JJ Lahuerta;J Blade;RZ Orlowski;JJ Shah
Journal / Conference
Leukemia 27(4):780-91
Year
2013
Research Committee(s)
Myeloma
PMID
PMID23288300
PMC
n/a - review article